PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.68M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-16.35%
Negative revenue growth while MTDR stands at 11.30%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-31.93%
Negative gross profit growth while MTDR is at 2.18%. Joel Greenblatt would examine cost competitiveness or demand decline.
-108.89%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-108.89%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-104.03%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-104.13%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-104.05%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-1.85%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.02%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
6.13%
Dividend growth of 6.13% while MTDR is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-3.44%
Negative OCF growth while MTDR is at 25.40%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-17.89%
Negative FCF growth while MTDR is at 22.83%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
179.63%
10Y revenue/share CAGR under 50% of MTDR's 1743.82%. Michael Burry would suspect a lasting competitive disadvantage.
-60.37%
Negative 5Y CAGR while MTDR stands at 27.11%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
25.85%
3Y revenue/share CAGR under 50% of MTDR's 198.33%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
-69.62%
Negative 10Y OCF/share CAGR while MTDR stands at 1077.14%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
59.63%
5Y OCF/share CAGR at 75-90% of MTDR's 75.97%. Bill Ackman would push for operational improvements to match competitor’s mid-term gains.
142.47%
3Y OCF/share CAGR under 50% of MTDR's 330.96%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
-100.55%
Negative 10Y net income/share CAGR while MTDR is at 939.29%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-101.73%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
98.59%
Positive short-term CAGR while MTDR is negative. John Neff would see a clear advantage in near-term profit trajectory.
-65.42%
Negative equity/share CAGR over 10 years while MTDR stands at 126.45%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-41.48%
Negative 5Y equity/share growth while MTDR is at 33.16%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
7.14%
Below 50% of MTDR's 116.58%. Michael Burry suspects a serious short-term disadvantage in building book value.
-90.36%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
-71.46%
Negative 5Y dividend/share CAGR while MTDR stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
18.03%
3Y dividend/share CAGR of 18.03% while MTDR is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-20.58%
Firm’s AR is declining while MTDR shows 2.28%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
No Data
No Data available this quarter, please select a different quarter.
0.61%
Asset growth well under 50% of MTDR's 3.38%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
1.98%
50-75% of MTDR's 3.02%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
0.24%
Debt shrinking faster vs. MTDR's 4.52%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
No Data
No Data available this quarter, please select a different quarter.
-95.62%
We cut SG&A while MTDR invests at 5.52%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.